Conference Coverage
Conference Coverage
Autologous Hematopoietic Stem Cells May Treat Aggressive MS Effectively
BERLIN—Autologous hematopoietic stem cell transplantation (HSCT) could prevent disease activity and promote functional...
Conference Coverage
Interferon Beta May Not Affect Pregnancy Outcomes in MS
BERLIN—European registry data do not support the hypothesis that exposure to interferon beta before conception or during...
Conference Coverage
Real-world data reveal long-lasting effects achieved with RRMS treatments
BERLIN –
Conference Coverage
Dietary sodium still in play as a potential MS risk factor
BERLIN – High-salt diets decimate Lactobacillus species, with downstream immune effects.
Conference Coverage
Breastfeeding with MS: Good for mom, too
Conference Coverage
Fatigue in MS: Common, often profound, tough to treat
BERLIN – Cognitive behavioral therapy carries the best evidence to treat MS-related fatigue.
Conference Coverage
Particular lesions early after CIS predict long-term MS disability
Conference Coverage
MS disease activity returns in one-third after fingolimod withdrawal
BERLIN – Risk factors for higher disease activity include younger age at diagnosis, shorter disease duration, and stopping more than 2 months...
Conference Coverage
Anti-MOG antibodies associated with non-MS, monophasic demyelinating disease in young children
BERLIN – Age and anti-MOG antibody status may help to predict a non-MS diagnosis.
Conference Coverage
Demyelinating diseases, especially MS, disrupt normal brain development in children